Noura
Pillar I · Standardized Industry Report

Hospitals — KSA Industry Report

Hospitals (General/Tertiary)Care DeliveryISIC 8610 Growth
Analyst-reviewedContains modeled estimatesVintage: 2026-06-21Refresh: quarterly

01

Summary

Saudi Arabia's hospital sector is large, government-dominated, and being deliberately pushed toward private participation — the highest-stakes segment in the Kingdom's healthcare transformation. The Kingdom has 499 hospitals and 80,072 beds (2023), of which government runs ~77% of beds and the private sector ~23%.

The hospital market is worth roughly USD 22–24bn (2024) and grows slowly on a same-store basis (~2.5–4.3% CAGR to 2030) — but the structural shift (privatization of 290 hospitals, mandatory-insurance expansion, a 35% private-bed target) is where the value moves, not the headline growth rate.

The sharpest opportunity is post-acute, rehabilitation and long-term care, where supply is structurally short — 8 post-acute beds per 100,000 vs 53 in the OECD, with 20,000–30,000 additional LTC/rehab beds needed by 2030. See the special focus and the dedicated Rehab/LTC report.

02

Market size

Hospital market value (Grand View anchor; alt. ~USD 24.4bn) · USD 22.05 bn · triangulated22.052024Hospital management market (USD 22.0bn 2024 → 37.1bn 2034) · USD 37.1 bn · triangulated37.12034USD bn
Market size (actual/latest)Forecast
Hospitals (total)
4992023Sourced
Hospital beds (total)
80,072 beds2023Sourced
Hospital market value (Grand View anchor; alt. ~USD 24.4bn)
USD 22.05 bn2024Triangulated
Broad healthcare market (context)
USD 139 bn2025Triangulated
03

Five-year forecast

Hospital management market (USD 22.0bn 2024 → 37.1bn 2034)
USD 37.1 bn2034Triangulated
Forecast CAGR (third-party range)
~2.5–5.4%2024–2034Modeled estimateMethod: Divergent independent third-party estimates (Grand View ~2.5%, alt. ~3.4–4.3%, hospital-management ~5.4%); treated as a range, not a point. A Noura proprietary driver-based, GASTAT-anchored forecast replaces this before commercial release.
Forecast assumptions
  • · Third-party market-value and forecast bands diverge and are flagged for replacement by a GASTAT-anchored Noura sizing.
  • · Structural mechanics (privatization, insurance expansion, 35% private-bed target) drive value more than the same-store growth rate.
04

Segmentation

Government beds (MoH ~59% + other-gov ~18%)77%Sourced
Private beds23%Sourced
05

Drivers & constraints

Drivers
  • Privatization pipeline

    Government plans to privatize 290 hospitals + 2,300 primary centers; a 35% private-bed-share target by 2030 ≈ doubling private capacity.

  • Insurance expansion

    Extending mandatory cover to Saudi nationals could add 12–15m insured lives, redirecting demand to private providers.

  • Demographics

    11%+ of the population aged 60+ by 2030; life-expectancy target 74→80.

  • Medical tourism

    USD 200m (2024) → 680m (2030), 22.5% CAGR (triangulated).

Constraints
  • Workforce shortage

    18 physiotherapists per 100,000 vs 110 in the OECD; plus Saudization pressure.

  • Reimbursement & value-based shift

    Purchasers moving toward value-based purchasing pressure margins.

  • Capital intensity

    Bed expansion is slow and capital-heavy.

06

Competitive landscape

Concentration (11 listed on Tadawul; one dominant champion)
Dominated by one champion (HMG)2024Sourced

11 listed healthcare companies on Tadawul posted ~USD 1.3bn combined profit in 2024. HMG dominates — SAR 11.2bn revenue, SAR 2.31bn net profit, SAR 95.7bn market cap — far ahead of a second tier (Mouwasat, Dallah, Al Hammadi, Fakeeh Care, Care, Saudi German, Al Moosa). A concentration index (HHI / top-3 bed share) is a modeled estimate pending per-operator bed counts in the Foundation.

07

Key players

Dr. Sulaiman Al Habib / HMG (SAR 11.2bn rev +17.8%, SAR 2.31bn profit, SAR 95.7bn cap) [S]Mouwasat Medical Services (SAR 2.87bn rev +6.4%, SAR 645.8m profit) [S]Fakeeh Care (SAR 10.5bn market cap) [S]Dallah Healthcare (listed) [S]Al Hammadi · Care · Saudi German · Al Moosa (listed) [S]
08

Special focus

Special focus — Rehabilitation & Long-Term Care

Post-acute supply is structurally short: ~8 post-acute beds per 100,000 people versus 53 in the OECD — roughly a 6× gap (sourced).

An estimated 20,000–30,000 additional LTC and rehab beds are needed by 2030; LTC + rehab bed demand rises from ~24,800 (2022) to ~35,800 (2030) (sourced).

The workforce gap mirrors the bed gap: 18 physiotherapists per 100,000 vs 110 in the OECD. Demand pull: the 60–79 cohort reaches ~4.63m by mid-2030 (sourced).

Operators moving into the gap include dedicated extended-care providers — e.g. Baraya Extended Care secured ~USD 124m for Saudi expansion (market operator) — alongside home-health arms of the listed acute groups (sourced).

Implication: acute hospitals cannot free beds without a post-acute discharge layer; this tier is the binding constraint on the acute system and the clearest under-served opening.

09

Outlook

Growth

Structural tailwind, neutral same-store. Don't read the ~2.5–4% headline as low interest — value sits in (a) the privatization transfer of 290 government hospitals to private operators and (b) the under-built post-acute/rehab tier the acute system depends on. Watch the CHI national-coverage extension as the demand trigger.

Regulatory factors
Ministry of Health (MOH)Council of Health Insurance (CHI) · NPHIESNational Center for Privatization (NCP)Saudi Commission for Health Specialties (SCFHS)Saudi Central Board for Accreditation of Healthcare Institutions (CBAHI)
10

Sources & methodology